Will The Coronavirus Be Different For This Perennial Disease Outbreak Loser?

As has been the case with many small-cap biotech stocks amid the coronavirus pandemic, traders have gotten excited in recent weeks about the stock examined in today’s article, one which, not that long ago, had fallen to as low as 10 cents per share and appeared to be heading towards bankruptcy. However, the stock in question generated similar excitement during past disease outbreaks, only for that enthusiasm to fade and shares to crash. Could this time be different – or is history likely to repeat? CLICK HERE.

Read More

These Coronavirus-Afflicted Sectors May Not Bounce Back Easily

While we have likely not even hit the peak of the coronavirus crisis yet, whenever the epidemic does come under control, many expect companies and markets impacted by the deadly virus to bounce back. However, as one fund manager cited in today’s article notes, “Everyone thinks everything is going to bounce if demand comes back, but previous incidents have shown that not every company will benefit the same way”. For three sectors – and specific companies within those sectors – that could face particularly difficult roads to recovery, CLICK HERE.

Read More

Coronavirus Survival Guide For Investors

In response to the spread of the new Chinese coronavirus – including its reaching the U.S. – U.S. stocks initially tumbled before rebounding as investors focused on positive earnings news. With more bad news and fear concerning the virus likely on the way, what will the virus’s impact be on the stock market? Today’s article provides a comprehensive look at the virus’s impact on Chinese stocks, China-exposed retailers, travel and gaming stocks, and biotech stocks – as well as what history suggests is coming next, potential buying opportunities from coronavirus-triggered selloffs and more. CLICK HERE.

Read More